Ramon L. Varcoe

Mar 19, 2024 | mdpi.com | Elizabeth Lim |Ramon L. Varcoe |R. L

All articles published by MDPI are made immediately available worldwide under an open access license. No specialpermission is required to reuse all or part of the article published by MDPI, including figures and tables. Forarticles published under an open access Creative Common CC BY license, any part of the article may be reused withoutpermission provided that the original article is clearly cited. For more information, please refer tohttps://www.mdpi.com/openaccess.

Feb 7, 2024 | hmpgloballearningnetwork.com | Ramon L. Varcoe

LIFE-BTK: Is There a Difference Between RC4 and RC5 Patients?|VDMRamon L. Varcoe, MBBS, MS, PhD, MMed (ClinEpi) Prince of Wales Hospital, Sydney, Australia In this video from ISET 2024, Ramon Varcoe, MBBS, MS, PhD, MMed (ClinEpi), discusses his presentation on the LIFE-BTK study, with an emphasis on the differences between patients with Rutherford Category 4 and and Rutherford Category 5.

Oct 24, 2023 | hmpgloballearningnetwork.com | Ramon L. Varcoe

No Excess Mortality Risk for Paclitaxel-Coated Devices | VDMRamon Varcoe, MBBS, PhDPrince of Wales Hospital, Sydney, Australia In this video recorded at AMP 2023, vascular surgeon Dr. Ramon Varcoe, from Prince of Wales Hospital in Sydney, Australia, talks about his presentation on the new FDA determination that paclitaxel-coated devices do not pose an excess mortality risk in patients and discusses the implications of this decision.